Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

A Parkinsonian syndrome in methcathinone users and the role of manganese.

Stepens A, Logina I, Liguts V, Aldins P, Eksteina I, Platkājis A, Mārtinsone I, Tērauds E, Rozentāle B, Donaghy M.

N Engl J Med. 2008 Mar 6;358(10):1009-17. doi: 10.1056/NEJMoa072488.

2.

VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease.

Chen MK, Kuwabara H, Zhou Y, Adams RJ, Brasić JR, McGlothan JL, Verina T, Burton NC, Alexander M, Kumar A, Wong DF, Guilarte TR.

J Neurochem. 2008 Apr;105(1):78-90. Epub 2007 Nov 5.

3.

High prevalence of Parkinsonian disorders associated to manganese exposure in the vicinities of ferroalloy industries.

Lucchini RG, Albini E, Benedetti L, Borghesi S, Coccaglio R, Malara EC, Parrinello G, Garattini S, Resola S, Alessio L.

Am J Ind Med. 2007 Nov;50(11):788-800.

PMID:
17918215
4.

The neuropathology of manganese-induced Parkinsonism.

Perl DP, Olanow CW.

J Neuropathol Exp Neurol. 2007 Aug;66(8):675-82. Review.

5.

Liver transplantation in a patient with rapid onset parkinsonism-dementia complex induced by manganism secondary to liver failure.

Fabiani G, Rogacheski E, Wiederkehr JC, Khouri J, Cianfarano A.

Arq Neuropsiquiatr. 2007 Sep;65(3A):685-8.

6.

Alpha-synuclein and its role in metal binding: relevance to Parkinson's disease.

Wright JA, Brown DR.

J Neurosci Res. 2008 Feb 15;86(3):496-503. Review.

PMID:
17705291
7.

Dopamine transporter SPECT of a liver cirrhotic with atypical parkinsonism.

Kim J, Kim JM, Kim YK, Shin JW, Choi SH, Kim SE, Kim Y.

Ind Health. 2007 Jun;45(3):497-500.

8.

Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease.

Koerts J, Leenders KL, Koning M, Portman AT, van Beilen M.

Eur J Neurosci. 2007 May;25(10):3132-6.

PMID:
17561826
9.
10.

D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons.

Surmeier DJ, Ding J, Day M, Wang Z, Shen W.

Trends Neurosci. 2007 May;30(5):228-35. Epub 2007 Apr 3. Review.

PMID:
17408758
11.

Inhibition of DAT function attenuates manganese accumulation in the globus pallidus.

Anderson JG, Cooney PT, Erikson KM.

Environ Toxicol Pharmacol. 2007 Mar;23(2):179-84.

12.

Parkinsonism caused by chronic usage of intravenous potassium permanganate.

Meral H, Kutukcu Y, Atmaca B, Ozer F, Hamamcioglu K.

Neurologist. 2007 Mar;13(2):92-4.

PMID:
17351530
13.

New insights into the mechanism of action of amphetamines.

Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR.

Annu Rev Pharmacol Toxicol. 2007;47:681-98. Review.

PMID:
17209801
14.

Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates.

Schneider JS, Decamp E, Koser AJ, Fritz S, Gonczi H, Syversen T, Guilarte TR.

Brain Res. 2006 Nov 6;1118(1):222-31. Epub 2006 Sep 15.

15.

Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study.

Guilarte TR, McGlothan JL, Degaonkar M, Chen MK, Barker PB, Syversen T, Schneider JS.

Toxicol Sci. 2006 Dec;94(2):351-8. Epub 2006 Sep 12.

16.

Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates.

Guilarte TR, Chen MK, McGlothan JL, Verina T, Wong DF, Zhou Y, Alexander M, Rohde CA, Syversen T, Decamp E, Koser AJ, Fritz S, Gonczi H, Anderson DW, Schneider JS.

Exp Neurol. 2006 Dec;202(2):381-90. Epub 2006 Aug 22.

PMID:
16925997
17.

An extended simplified reference tissue model for the quantification of dynamic PET with amphetamine challenge.

Zhou Y, Chen MK, Endres CJ, Ye W, Brasić JR, Alexander M, Crabb AH, Guilarte TR, Wong DF.

Neuroimage. 2006 Nov 1;33(2):550-63. Epub 2006 Aug 21.

PMID:
16920365
18.

Motor alterations associated with exposure to manganese in the environment in Mexico.

Rodríguez-Agudelo Y, Riojas-Rodríguez H, Ríos C, Rosas I, Sabido Pedraza E, Miranda J, Siebe C, Texcalac JL, Santos-Burgoa C.

Sci Total Environ. 2006 Sep 15;368(2-3):542-56. Epub 2006 Jun 21.

PMID:
16793118
19.

Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia.

Newell KA, Deng C, Huang XF.

Exp Brain Res. 2006 Jul;172(4):556-60. Epub 2006 May 19.

PMID:
16710682
Items per page

Supplemental Content

Write to the Help Desk